Market closed· · USD · Data may be delayed
Avg. target $16.00 (+53.1%)
Prices may be delayed and are for informational purposes only - not investment advice.
Calculated from the tables below and the current price ($10.45) · 2026/6 · Q2 · 2026-06-30
Latest quarter: flow lines (revenue, earnings, EPS, cash flow) are annualised (x4) and ignore seasonality. Book value and liabilities / equity come from the quarter-end balance sheet.
Fiscal year · $ millions · net margin below
| Fiscal year | Trend | 2023 | 2024 | LTM |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | 230,100 | 192,216-16% | 188,368 | |
| Cost of Revenue | ||||
| Gross Profit | ||||
| Operating expenses | ||||
| Operating Income | ||||
| EBITDA | ||||
| Pre-tax income | ||||
| Income tax (expense) / benefit | ||||
| Net Income | 95,660 | 100,898+5% | 10,321 | |
| Earnings per share ($) | ||||
| Margins | ||||
| Gross margin | ||||
| Operating margin | ||||
| EBITDA margin | ||||
| Net margin | ||||
Standardised statements compiled from the company's annual and interim reports. The "LTM" column covers the last four reported quarters; balance-sheet lines in it are from the latest quarter. Lines the company does not report are left blank rather than approximated. Not investment advice.